Ethics approval
The protocol for the DIAMONDS trial was approved by the Office for Research Ethics Committees Northern Ireland (ORECNI 15/NI/0197). A Clinical Trial Authorisation (CTA) was obtained from the Medicines and Healthcare products Regulatory Agency (MHRA) (32485/0029/001-0001).